Cardiff and Vale University Health Board

Cardiff CF14 4XW

2 studies enrolling now · 3 studies all time

What they study most

Dravet Syndrome, Immunoglobulin A (IgA) Nephropathy, Neovascular Age-related Macular Degeneration (nAMD)

Studies at this site

• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome — Recruiting now
• PS-002 for the Treatment of IgA Nephropathy in Adults — Recruiting now
• A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration — Running, not enrolling